Received: 27 April 2022
Accepted: 14 July 2022
First Online: 18 July 2022
: Ethical approval and clearance were obtained from Dilla University, college of Medicine & Health science Institutional Review Board with the unique ethical approval number of ducm/irb/044/2022. Before informed consent and assent were obtained, a clear description of the study title, purpose, procedure and duration, and possible risk benefits of the study was explained to each study participant and their parents/legal guardians for those who are unable to read and write. Informed and signed consent for participants who are unable to read and write was obtained from their parents/legal guardians (legally authorized representatives). For the study participants aged less than 18, informed consent was obtained from their parents/legal guardians (legally authorized representatives) and all participants aged less than 18 signed an assent form. Their right during the interview was guaranteed. Participants’ involvement in the study was totally voluntary, and those who were unwilling to participate in the study and those who wished to quit their participation at any stage were informed to do so without any restriction. By not including the names of the participants in the questionnaire, confidentiality was preserved at all levels of the study. The obtained data was kept under lock and key for security concerns and was only utilized for the objectives of the study. All necessary methods were carried out in accordance with the guidelines of the institutional and Declaration of Helsinki. This manuscript conforms the Enhancing the Quality and Transparency Of health Research (EQUATOR) network guidelines.
: Informed consent has been obtained from all participants and from their parents/legal guardians (legally authorized representatives) of minors, and who are unable to read and write to publish the information included in this manuscript in an online open-access publication.
: The authors declare that they have no competing interests.